Foresite Capital Management IV, LLC

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Foresite Capital Management IV, LLC's trades of Eikon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-06 2026-02-04
B Purchase
33,439 -38.2%
159.84
US$2,732,936 		33,439 -38.2% 159.84 US$2,732,936
2023-05-10 2023-05-08
B Purchase
98,802 +47.6%
299.87
US$2,730,835 		98,802 +47.6% 299.87 US$2,730,835
2023-05-10 2023-05-08
B Purchase
80,978 +40.7%
436.51
US$1,185,047 		80,978 +40.7% 436.51 US$1,185,047